Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 4, 2014, Pages

  Puskas, John ^a   Gerdisch, Marc ^b   Nichols, Dennis ^b   Quinn, Reed ^b   Anderson, Charles ^b   Rhenman, Birger ^c   Fermin, Lilibeth ^c   McGrath, Michael ^d   Kong, Bobby ^e   Hughes, Chad ^f   Sethi, Gulshan ^g   Wait, Michael ^h   Martin, Tomas ⁱ   Graeve, Allen ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Franciscan St Francis Health ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SENTARA NORFOLK GENERAL HOSPITAL   (United States)

^e ST JOSEPH MERCY HOSPITAL   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; ANTICOAGULATION; AORTA ANEURYSM; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CROSSOVER PROCEDURE; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HOME MONITORING; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PARAVALVULAR LEAK; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE ENDOCARDITIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SINUS RHYTHM; SURGICAL MORTALITY; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ANTICOAGULANTS; AORTIC VALVE; ASPIRIN; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOEMBOLISM; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WARFARIN;

EID: 84896549026     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.01.004     Document Type: Article

References (25)

1. N.G. Smedira, E.H. Blackstone, E.E. Roselli, C.C. Laffey, and D.M. Cosgrove Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses J Thorac Cardiovasc Surg 131 2006 558 564
2. C. Akins Results with mechanical cardiac valvular prostheses Ann Thorac Surg 60 1995 1836 1844
3. S. Khan, A. Trento, M. DeRobertis, R.M. Kass, M. Sandhu, and L.S. Czer et al. Twenty-year comparison of tissue and mechanical valve replacement J Thorac Cardiovasc Surg 122 2001 257 269
4. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation 118 2008 e523 e661
5. P.D. Stein, J.S. Alpert, H.I. Bussey, J.E. Dalen, and A.G. Turpie Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 119 2001 220S 227S
6. C.W. Akins, D.C. Miller, M.I. Turina, N.T. Kouchoukos, E.H. Blackstone, and G.L. Grunkemeier et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions J Thorac Cardiovasc Surg 135 2008 732 738
7. F.R. Rosendaal, S.C. Cannegieter, F.J.M. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
8. S.C. Cannegieter, F.R. Rosendaal, A.R. Wintzen, F.J.M. van der Meer, J.P. Vandenbroucke, and E. Briet Optimal oral anticoagulant therapy in patients with mechanical heart valves N Engl J Med 333 1995 11 17
9. D. Horstkotte, H.D. Schulte, W. Bircks, and B.E. Strauer Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis J Thorac Cardiovasc Surg 107 1994 1136 1145
10. E.G. Butchart Prosthetic heart valves M. Verstraete, V. Fuster, E.J. Topol, Cardiovascular Thrombosis: Thrombocardiology and Thromboneurology 2nd ed. 1998 Lippincott-Raven Philadelphia 395 413
11. M. Torella, D. Torella, P. Chiodini, M. Franciulli, G. Romano, and L. De Santo et al. Lowering the intensity of oral anticoagulant therapy in patients with bileaflet mechanical aortic valve replacement: results from the LOWERING-IT trial Am Heart J 160 2010 171 178
12. P.V. Anderson, and J. Aagaard Low-dose warfarin in patients with Carbomedics heart valve prostheses Asian Cardiovasc Thorac Ann 8 2000 11 14
13. J. Acar, B. Iung, J.P. Boissel, M.M. Samama, P.L. Michel, and J.P. Teppe et al. AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves Circulation 94 1996 2107 2112
14. A.G.G. Turpie, M. Gent, A. Laupagcis, Y. Latour, J. Gunstensen, and F. Basile et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 1993 524 529
15. D. Skudicky, M.R. Essop, T. Wisenbaugh, J. Skoularigis, A.R. Essop, and A. Dullabh et al. Frequency of prosthetic valve-related complications with very low level warfarin anticoagulation combined with dipyridamole after valve replacement using St. Jude Medical prostheses Am J Cardiol 74 1994 1137 1141
16. B. Yamak, Z. Iscan, B. Mavitas, A.T. Ulus, S.F. Katricioglu, and O. Tasdemir et al. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical Heart Valve prosthesis J Heart Valve Dis 8 1999 665 673
17. R. Altman, J. Rouvier, E. Gurfinkel, A. Scazziota, and A.G.G. Turpie Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant Circulation 94 1996 2113 2116
18. J.C. Cappelleri, L.D. Fiore, M.T. Brophy, D. Deykin, and J. Lau Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a meta-analysis Am Heart J 130 1995 547 552
19. H. Körtke, and R. Körfer International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 72 2001 44 48
20. E.G. Butchart, N. Payne, H.H. Li, K. Buchan, K. Mandana, and G.L. Grunkemeier Better anticoagulation control improves survival after valve replacement J Thorac Cardiovasc Surg 123 2002 715 723
21. J. Bamford, and C.P. Warlow Stroke and TIA in the general population E.G. Butchart, E. Bodnar, Current Issues in Heart Valve Disease: Thrombosis, Embolism and Bleeding 1992 ICR London 3 15
22. ® Prosthetic Heart Valve: intermediate follow-up Ann Thorac Surg 83 2007 40 46
23. M.A. Williams, and S. van Riet The On-X heart valve - mid-term results in a poorly anticoagulated population J Heart Valve Dis 15 2006 80 86
24. J.B. Chambers, J.L. Pomar, C.A. Mestres, and G.M. Palatianos Clinical event rates with the On-X bileaflet mechanical heart valve: a multicenter experience with follow-up to 12 years Thorac Cardiovasc Surg 145 2013 420 424
25. ® carbon for mechanical heart valve prostheses J Heart Valve Dis 7 1998 626 632